研究文章

炎症因子在肺-肠轴中的研究进展

摘要

肺-肠轴是介导呼吸与消化器官间黏膜免疫双向调控的重要网络,炎症因子是实现肺肠免疫串扰的关键介质。肺、肠道黏膜具有同源免疫结构,炎症信号可通过血液循环、菌群代谢产物、淋巴细胞归巢完成跨器官传导。TNF-α、IL-6、IL-17、IL-22、TGF-β等炎症因子存在组织特异性与剂量依赖性双重作用,因子表达失衡参与慢阻肺、哮喘、ARDS及炎症性肠病等肺肠共病的发生进展。现有研究提示,外周血炎症因子检测不能完全代表黏膜局部免疫水平,给疾病标志物挖掘与靶向干预带来局限。本文综述上述核心炎症因子的调控机制、信号通路及与相关疾病的关联,总结基于肺-肠轴的干预思路,以及为阐释肺肠共病发病机制、发掘新的治疗靶点提供理论参考。

关键词

肺-肠轴;炎症因子;免疫串扰;肠道菌群;黏膜免疫

参考

Zhang Z, Liu H, Su Y, et al. Pulmonary-Intestinal Axis:Shared Genetic Basis and Mediating Factors Identified Through Multi-Omics Analysis[J]. Int J Chron Obstruct Pul-mon Dis,2026,21:561645.

Liu J, Huang Y, Liu N, et al. The imbalance of pulmonaryTh17/Treg cells in BALB/c suckling mice infected with respiratory syncytial virus-mediated intestinal immune dam-age and gut microbiota changes[J]. Microbiol Spectr,2024,-12(6):e0328323.

Stricker S, Hain T, Chao C M, et al. Respiratory and Inte-stinal Microbiota in Pediatric Lung Diseases-Current Evi-dence of the Gut-Lung Axis[J]. Int J Mol Sci,2022,23(12):-6791.

Nath S, Kitsios G D, Bos L D J. Gut-lung crosstalk duringcritical illness[J]. Curr Opin Crit Care,2023,29(2):130-137.

Kamiki J, Gorgulho C M, Lérias J R, et al. Mucosal-associ-ated invariant T-cells in pulmonary pathophysiology[J].Curr Opin Pulm Med,2025,31(3):202-210.

Li Q, Song X C, Li K, et al. Gut-lung immunometaboliccrosstalk in sepsis: from microbiota to respiratory failure[-J]. Front Med,2025,12:1685044.

Wang L, Pelgrim C E, Peralta Marzal L N, et al. Changesin intestinal homeostasis and immunity in a cigarette smo-ke- and LPS-induced murine model for COPD: the lung-g-ut axis[J]. Am J Physiol Lung Cell Mol Physiol,2022,323(-3):L266-L280.

Khilwani R, Singh S. Dual signaling cascade regulating gut-lung axis in Interleukin-6/Interleukin-17 for NSCLC immuno pathogenesis[J]. Front Immunol,2025,16:1649517.

Tang J, Xu L, Zeng Y, et al. Effect of gut microbiota onLPS-induced acute lung injury by regulating the TLR4/N-F-kB signaling pathway[J]. Int Immunopharmacol,2021,91:-107272.

Raftery A L, Tsantikos E, Harris N L, et al. Links Betwe-en Inflammatory Bowel Disease and Chronic ObstructivePulmonary Disease[J]. Front Immunol,2020,11:2144.

Lv J, Zhang Y, Liu S, et al. Gut-lung axis in allergic ast-hma: microbiota-driven immune dysregulation and thera-peutic strategies[J]. Front Pharmacol,2025,16:1617546.

Jia Y, He T, Wu D, et al. The treatment of Qibai PingfeiCapsule on chronic obstructive pulmonary disease maybe mediated by Th17/Treg balance and gut-lung axis mi-crobiota[J]. J Transl Med,2022,20(1):281.

Wei Y, Li T, Zhao D, et al. Sodium butyrate amelioratessepsis-associated lung injury by enhancing gut and lun gbarrier function in combination with modulation of CD4⁺Foxp3⁺ regulatory T cells[J]. Eur J Pharmacol,2024,963-:176219.

Jia M, Liu Y, Liu J, et al. Xuanfei Baidu decoction amel-iorates bleomycin-elicited idiopathic pulmonary fibrosisin mice by regulating the lung-gut crosstalk via IFNγ/ST-AT1/STAT3 axis[J]. Phytomedicine,2024,135:155997.

de Oliveira G L V, Oliveira C N S, Pinzan C F, et al. Mi-crobiota Modulation of the Gut-Lung Axis in COVID-19-[J]. Front Immunol,2021,12:635471.31

Refbacks

  • 当前没有refback。
版权所有(c)2026 玉昆 王, 淑平 佟
Creative Commons License
此作品已接受知识共享署名-非商业性使用 4.0国际许可协议的许可。